Martin Widschwendter

Martin Widschwendter

Affiliated to Research
Visiting address: BioMedicum A4, Solnavägen 9, 17165 Solna
Postal address: K6 Kvinnors och barns hälsa, K6 NOGRH Gemzell Danielsson, 171 77 Stockholm
Part of:

About me

  • Visiting Professor of women’s cancer at the Department of Women’s and
    Children’s Health from July 1, 2020.
    Primary position: Professor of Women’s Cancer at the University of
    Innsbruck, Austria, and the University College London, UK.

Research

  • Professor Martin Widschwendter’s research focuses on cancers of the breast,
    uterus, cervix, and ovaries, with his long-term goal being the elimination of
    women-specific cancers. His research spans four areas: mechanisms of disease,
    risk assessment, prevention, and early diagnosis. His mechanisms of disease
    research comprises, amongst other considerations, why the BRCA1 gene leads to
    a much higher risk particularly for breast cancer, and how women with BRCA1
    have elevated levels of progesterone during certain phases of the menstrual
    cycle.
    His risk assessment research focuses on epigenetic markers in cervical
    samples and has been carried out with a number of collaborators including
    Joakim Dillner’s research team at KI. Professor Widschwendter has an
    established collaboration project with Kristina Gemzell Danielsson’s
    research team at KI regarding the use of progesterone antagonists as
    potential prevention. His research on early diagnosis focuses on the
    detection of tumour DNA in blood samples, with the aim of developing a
    screening programme.
    /Text: From Cell to Society, 2020/

Articles

All other publications

  • Review: NATURE AGING. 2024;4(10):1372-1383
    Herzog CMS; Goeminne LJE; Poganik JR; Barzilai N; Belsky DW; Betts-LaCroix J; Chen BH; Chen M; Cohen AA; Cummings SR; Fedichev PO; Ferrucci L; Fleming A; Fortney K; Furman D; Gorbunova V; Higgins-Chen A; Hood L; Horvath S; Justice JN; Kiel DP; Kuchel GA; Lasky-Su J; Lebrasseur NK; Maier AB; Schilling B; Sebastiano V; Slagboom PE; Snyder MP; Verdin E; Widschwendter M; Zhavoronkov A; Moqri M; Gladyshev VN
  • Review: NATURE MEDICINE. 2024;30(2):360-372
    Moqri M; Herzog C; Poganik JR; Ying K; Justice JN; Belsky DW; Higgins-Chen AT; Chen BH; Cohen AA; Fuellen G; Haegg S; Marioni RE; Widschwendter M; Fortney K; Fedichev PO; Zhavoronkov A; Barzilai N; Lasky-Su J; Kiel DP; Kennedy BK; Cummings S; Slagboom PE; Verdin E; Maier AB; Sebastiano V; Snyder MP; Gladyshev VN; Horvath S; Ferrucci L
  • Review: CELL. 2023;186(18):3758-3775
    Moqri M; Herzog C; Justice J; Belsky DW; Higgins-Chen A; Moskalev A; Fuellen G; Cohen AA; Bautmans I; Widschwendter M; Ding J; Fleming A; Mannick J; Han J-DJ; Zhavoronkov A; Barzilai N; Kaeberlein M; Cummings S; Kennedy BK; Ferrucci L; Horvath S; Verdin E; Maier AB; Snyder MP; Sebastiano V; Gladyshev VN
  • Review: INTERNATIONAL JOURNAL OF CANCER. 2023;152(6):1060-1068
    Lehtinen M; Pimenoff VN; Nedjai B; Louvanto K; Verhoef L; Heideman DAM; El-Zein M; Widschwendter M; Dillner J
  • Review: NATURE REVIEWS CLINICAL ONCOLOGY. 2020;17(11):687-705
    Pashayan N; Antoniou AC; Ivanus U; Esserman LJ; Easton DF; French D; Sroczynski G; Hall P; Cuzick J; Evans DG; Simard J; Garcia-Closas M; Schmutzler R; Wegwarth O; Pharoah P; Moorthie S; De Montgolfier S; Baron C; Herceg Z; Turnbull C; Balleyguier C; Rossi PG; Wesseling J; Ritchie D; Tischkowitz M; Broeders M; Reisel D; Metspalu A; Callender T; de Koning H; Devilee P; Delaloge S; Schmidt MK; Widschwendter M
  • Review: NATURE REVIEWS CLINICAL ONCOLOGY. 2018;15(5):292-309
    Widschwendter M; Jones A; Evans I; Reiser D; Dillner J; Sundstrom K; Steyerberg EW; Vergouwe Y; Wegwarth O; Rebitschek FG; Siebert U; Sroczynski G; de Beaufort ID; Bolt I; Cibula D; Zikan M; Bjorge L; Colombo N; Harbeck N; Dudbridge F; Tasse A-M; Knoppers BM; Joly Y; Teschendorff AE; Pashayan N

News from KI

Events from KI